 Growth human cerebral meningiomas dopaminergic agents Presence high affinity receptors microM concentrations dopamine agonist bromocriptine proliferation rate human meningioma cells culture inhibition effect direct application dopamine agonist microM concentrations cell cultures Receptor studies ligand antagonist binding sites present membranes meningioma tissue mean dissociation constant Kd SEM pM receptor density Bmax SEM pellet protein human meningiomas pharmacological specificity -butaclamol inactive isomers -butaclamol fold excess results evidence human meningiomas possess high affinity receptors dopamine agonists antiproliferative effect tumors culture proliferation cerebral meningiomas dopaminergic control dopamine agonists role medical treatment patients meningiomas